Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market
Holding RGBP?
Track your performance easily

Regen Biopharma (RGBP) Stock Price & Analysis

116 Followers

RGBP Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
Insiders
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

RGBP FAQ

What was Regen Biopharma’s price range in the past 12 months?
Regen Biopharma lowest stock price was $0.02 and its highest was $0.78 in the past 12 months.
    What is Regen Biopharma’s market cap?
    Currently, no data Available
    When is Regen Biopharma’s upcoming earnings report date?
    Regen Biopharma’s upcoming earnings report date is May 14, 2018 which is 2375 days ago.
      How were Regen Biopharma’s earnings last quarter?
      Currently, no data Available
      Is Regen Biopharma overvalued?
      According to Wall Street analysts Regen Biopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Regen Biopharma pay dividends?
        Regen Biopharma pays a Notavailable dividend of $0.06 which represents an annual dividend yield of N/A. See more information on Regen Biopharma dividends here
          What is Regen Biopharma’s EPS estimate?
          Regen Biopharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Regen Biopharma have?
          Regen Biopharma has 10,016,640 shares outstanding.
            What happened to Regen Biopharma’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Regen Biopharma?
            Currently, no hedge funds are holding shares in RGBP
            ---

            Regen Biopharma Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Company Description

            Regen Biopharma

            Regen Biopharma, Inc. engages in the development of regenerative medical applications licensed from other companies. It focuses on the immunology and immonutherapy research for the areas of Hematopoiesis, Breast Cancer, Liver Cancer, Leukemia, Myelodysplastic Syndrome, and Aplastic Anemia. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Advaxis
            Cyclacel Pharmaceuticals
            Plus Therapeutics
            TRACON Pharmaceuticals
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis